Journal Article
. 2009 Apr; 94(1):156-66.
doi: 10.1016/j.fertnstert.2009.02.043.

Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age

Mikkel Rosendahl 1 Claus Yding Andersen  Nina la Cour Freiesleben  Anders Juul  Kristine Løssl  Anders Nyboe Andersen  
Affiliations
  • PMID: 19342041
  •     31 citations

Abstract

Objective: To study ovarian follicular dynamics during chemotherapy to understand the mechanisms behind chemotherapy-induced ovarian follicular depletion and to evaluate whether pretreatment levels of ovarian reserve markers were predictive of the posttreatment levels.

Design: Prospective clinical study.

Setting: University hospital fertility center.

Patient(S): Seventeen women (median age 30 years; range 19-35 years) undergoing chemotherapy.

Intervention(S): Patients were seen before, frequently during, and after chemotherapy, until 1 year after the end of treatment. Antral follicle count and levels of FSH, LH, E(2), anti-Müllerian hormone (AMH), and inhibin A and B were monitored at each visit.

Main Outcome Measure(S): The dynamics of the ovarian reserve markers during chemotherapy and factors predictive of posttreatment ovarian function.

Result(S): Anti-Müllerian hormone level (mean +/- 2 SEM) dropped from 2.7 +/- 1.0 to 1.1 +/- 0.6 and to 0.4 +/- 0.4 ng/mL immediately after one and two series of chemotherapy, respectively. Inhibin B and antral follicle count decreased after three series whereas FSH reached menopausal levels after four series. High pretreatment AMH levels predicted higher posttreatment AMH levels.

Conclusion(S): Anti-Müllerian hormone and inhibin B levels immediately declined in response to chemotherapy, and the follicular target of chemotherapy appeared to be growing follicles. High pretreatment AMH levels were predictive of a higher posttreatment AMH level.

The Gynecologist Has a Unique Role in Providing Oncofertility Care to Young Cancer Patients.
Francesca E Duncan, Jennifer K Jozefik, +2 authors, Teresa K Woodruff.
US Obstet Gynecol, 2011 Sep 20; 6(1). PMID: 21927621    Free PMC article.
Creating a continuum of care: integrating obstetricians and gynecologists in the care of young cancer patients.
Betty Y Kong, Robin M Skory, Teresa K Woodruff.
Clin Obstet Gynecol, 2011 Oct 28; 54(4). PMID: 22031251    Free PMC article.
Review.
Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management.
Dana Shanis, Melissa Merideth, +3 authors, Pamela Stratton.
Semin Hematol, 2012 Jan 10; 49(1). PMID: 22221788    Free PMC article.
Review.
Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency.
Jenny A Visser, Izaäk Schipper, Joop S E Laven, Axel P N Themmen.
Nat Rev Endocrinol, 2012 Jan 11; 8(6). PMID: 22231848
Review.
The risk of amenorrhea is related to chemotherapy-induced leucopenia in breast cancer patients receiving epirubicin and taxane based chemotherapy.
Wenbin Zhou, Qiang Ding, +4 authors, Shui Wang.
PLoS One, 2012 May 23; 7(5). PMID: 22615953    Free PMC article.
The mechanism of mesna in protection from cisplatin-induced ovarian damage in female rats.
Xiaohuan Li, Shu Yang, +4 authors, Deshan Zhou.
J Gynecol Oncol, 2013 May 09; 24(2). PMID: 23653836    Free PMC article.
Fertility counseling of young breast cancer patients.
Matteo Lambertini, Paola Anserini, +2 authors, Lucia Del Mastro.
J Thorac Dis, 2013 Jul 03; 5 Suppl 1. PMID: 23819030    Free PMC article.
Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer.
Richard A Anderson, Mikkel Rosendahl, Thomas W Kelsey, David A Cameron.
Eur J Cancer, 2013 Aug 24; 49(16). PMID: 23968732    Free PMC article.
Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review.
Maëliss Peigné, Christine Decanter.
Reprod Biol Endocrinol, 2014 Mar 29; 12. PMID: 24666685    Free PMC article.
Systematic Review.
A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer.
Joyce Chai, A Forbes Howie, David A Cameron, Richard A Anderson.
Eur J Cancer, 2014 Jul 17; 50(14). PMID: 25027307    Free PMC article.
Reproductive health and endocrine disruption in women with breast cancer: a pilot study.
Ashlesha Patel, Alicia Roston, +4 authors, H A Zaren.
Support Care Cancer, 2014 Aug 15; 23(2). PMID: 25120011
Amniotic fluid stem cells prevent follicle atresia and rescue fertility of mice with premature ovarian failure induced by chemotherapy.
Guan-Yu Xiao, I-Hsuan Liu, +4 authors, Shinn-Chih Wu.
PLoS One, 2014 Sep 10; 9(9). PMID: 25198549    Free PMC article.
Effect of Previous Chemotherapy on the Quality of Cryopreserved Human Ovarian Tissue In Vitro.
Babak Asadi Azarbaijani, Mona Sheikhi, +7 authors, Kirsi Jahnukainen.
PLoS One, 2015 Aug 01; 10(7). PMID: 26226487    Free PMC article.
Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram.
Agnese Barnabei, Lidia Strigari, +4 authors, Francesco Torino.
Oncologist, 2015 Sep 06; 20(10). PMID: 26341758    Free PMC article.
Fertility Preservation for the Young Breast Cancer Patient.
Shari B Goldfarb, Sabrina A Kamer, +6 authors, Mary L Gemignani.
Ann Surg Oncol, 2016 Jan 23; 23(5). PMID: 26790670    Free PMC article.
Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers.
Zehra Jamil, Syeda Sadia Fatima, Khalid Ahmed, Rabia Malik.
Dis Markers, 2016 Mar 16; 2016. PMID: 26977116    Free PMC article.
Review.
Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy.
Guan-Yu Xiao, Chun-Chun Cheng, +3 authors, Shinn-Chih Wu.
Sci Rep, 2016 Mar 17; 6. PMID: 26979400    Free PMC article.
Severe gonadotoxic insult manifests early in young girls treated for Ewing sarcoma.
Helena Mörse, Maria Elfving, +2 authors, Ingrid Øra.
Medicine (Baltimore), 2016 Aug 19; 95(33). PMID: 27537574    Free PMC article.
Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?
Akira Iwase, Tomoko Nakamura, +3 authors, Fumitaka Kikkawa.
Reprod Med Biol, 2015 Nov 23; 15(3). PMID: 29259429    Free PMC article.
Review.
Anti-Müllerian hormone levels in patients with gestational trophoblastic neoplasia treated with different chemotherapy regimens: a prospective cohort study.
Xiaoning Bi, Jingjing Zhang, +8 authors, Keng Shen.
Oncotarget, 2018 Jan 27; 8(69). PMID: 29371957    Free PMC article.
Preliminary human application of optical coherence tomography for quantification and localization of primordial follicles aimed at effective ovarian tissue transplantation.
Seido Takae, Kosuke Tsukada, +6 authors, Nao Suzuki.
J Assist Reprod Genet, 2018 Apr 03; 35(4). PMID: 29607457    Free PMC article.
Antral follicle count recovery in women with menses after treatment with and without gonadotropin-releasing hormone agonist use during chemotherapy for breast cancer.
N Sinha, J M Letourneau, +7 authors, Mitchell P Rosen.
J Assist Reprod Genet, 2018 Aug 02; 35(10). PMID: 30066303    Free PMC article.
Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery
Hyun-Ah Kim, Jihye Choi, +7 authors, The ASTRRA trial investigators.
Endocr Connect, 2018 Oct 10; 7(8). PMID: 30300533    Free PMC article.
Counseling young women with early breast cancer on fertility preservation.
M E Elena Ter Welle-Butalid, I J H Ingeborg Vriens, +5 authors, V C G Vivianne Tjan-Heijnen.
J Assist Reprod Genet, 2019 Nov 25; 36(12). PMID: 31760547    Free PMC article.
Ovarian tissue cryopreservation: Low usage rates and high live-birth rate after transplantation.
Ellen J Hoekman, Leoni A Louwe, +5 authors, Carina G J M Hilders.
Acta Obstet Gynecol Scand, 2019 Sep 21; 99(2). PMID: 31538662    Free PMC article.
The survival effect of ovary preservation in early stage endometrial cancer: a single institution retrospective analysis.
Wonkyo Shin, Sang-Yoon Park, +2 authors, Sang-Soo Seo.
J Ovarian Res, 2020 Aug 24; 13(1). PMID: 32828125    Free PMC article.
Mechanistic perspective of protective effects of resveratrol against cisplatin-induced ovarian injury in rats: emphasis on anti-inflammatory and anti-apoptotic effects.
Riham S Said, Eman M Mantawy, Ebtehal El-Demerdash.
Naunyn Schmiedebergs Arch Pharmacol, 2019 May 28; 392(10). PMID: 31129703
Human embryonic stem cell-derived mesenchymal stem cells improved premature ovarian failure.
Khadijeh Bahrehbar, Mojtaba Rezazadeh Valojerdi, +3 authors, Hossein Baharvand.
World J Stem Cells, 2020 Sep 22; 12(8). PMID: 32952863    Free PMC article.
FertiPROTEKT, Oncofertility Consortium and the Danish Fertility-Preservation Networks - What Can We Learn From Their Experiences?
Michael von Wolff, Claus Yding Andersen, Teresa K Woodruff, Frank Nawroth.
Clin Med Insights Reprod Health, 2019 May 10; 13. PMID: 31068758    Free PMC article.
Review.
Anti-Müllerian Hormone in Fertility Preservation: Clinical and Therapeutic Applications.
Charlotte Sonigo, Isabelle Beau, Nadine Binart, Michael Grynberg.
Clin Med Insights Reprod Health, 2019 Jul 02; 13. PMID: 31258345    Free PMC article.
Review.